John Trizzino
Presidente en NOVAVAX, INC. .
Fortuna: 587 508 $ al 31/05/2024
Perfil
El Sr. John J. Trizzino es director financiero, vicepresidente ejecutivo, director comercial y de negocios de Novavax, Inc. El Sr. Trizzino trabajó anteriormente como director ejecutivo y director de ImmunoVaccine, Inc., vicepresidente de la franquicia de vacunas de MedImmune LLC, vicepresidente de desarrollo comercial de ID Biomedical Corp. y vicepresidente de desarrollo comercial de Henry Schein, Inc. También formó parte de la junta directiva de Tech Council of Maryland, Inc. Se licenció en la Universidad de Long Island y obtuvo un MBA en la Leonard N Stern School of Business.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NOVAVAX, INC.
0.03% | 22/04/2024 | 39 089 ( 0.03% ) | 587 508 $ | 31/05/2024 |
Cargos activos de John Trizzino
| Empresas | Cargo | Inicio |
|---|---|---|
| NOVAVAX, INC. | Presidente | 20/11/2023 |
Antiguos cargos conocidos de John Trizzino.
| Empresas | Cargo | Fin |
|---|---|---|
| IMV INC. | Director Ejecutivo | 01/09/2013 |
| NOVAVAX, INC. | Corporate Officer/Principal | 06/09/2011 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 01/01/2009 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01/01/2009 |
| HENRY SCHEIN, INC. | Corporate Officer/Principal | 01/01/2004 |
Formación de John Trizzino.
| Long Island University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| HENRY SCHEIN, INC. | Distribution Services |
| NOVAVAX, INC. | Health Technology |
| IMV INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Tech Council of Maryland, Inc.
 Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Commercial Services |
- Bolsa de valores
- Insiders
- John Trizzino
